Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Analysts

Stevanato Group S.p.A. (NYSE:STVN) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company.

Several research analysts have recently issued reports on STVN shares. Wolfe Research started coverage on shares of Stevanato Group in a report on Tuesday. They issued an “outperform” rating and a $21.00 target price for the company. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a report on Tuesday, February 10th. Citigroup lowered their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a report on Thursday, March 5th. Weiss Ratings cut shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 11th. Finally, KeyCorp lowered their target price on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, March 5th.

Stevanato Group Stock Up 0.4%

Shares of NYSE STVN opened at €18.59 on Friday. The company has a market capitalization of $5.63 billion, a price-to-earnings ratio of 31.51, a price-to-earnings-growth ratio of 1.71 and a beta of 0.78. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.63 and a quick ratio of 1.11. The business has a 50-day moving average of €16.32 and a two-hundred day moving average of €17.79. Stevanato Group has a 1 year low of €12.89 and a 1 year high of €28.00.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The business had revenue of €273.57 million for the quarter. During the same period last year, the business earned $0.10 earnings per share. Stevanato Group’s revenue was up 6.6% compared to the same quarter last year. On average, analysts forecast that Stevanato Group will post 0.68 earnings per share for the current fiscal year.

Stevanato Group Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Wednesday, July 29th. Investors of record on Thursday, June 11th will be paid a dividend of $0.054 per share. The ex-dividend date is Thursday, June 11th. This represents a yield of 29.0%.

Institutional Trading of Stevanato Group

A number of large investors have recently bought and sold shares of the business. ArrowMark Colorado Holdings LLC increased its holdings in shares of Stevanato Group by 6.7% in the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 1,392,581 shares of the company’s stock valued at $35,859,000 after purchasing an additional 86,971 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Stevanato Group by 7.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock worth $61,089,000 after purchasing an additional 156,733 shares during the last quarter. Cooper Investors PTY Ltd. boosted its stake in shares of Stevanato Group by 17.8% during the 4th quarter. Cooper Investors PTY Ltd. now owns 695,245 shares of the company’s stock worth $13,988,000 after purchasing an additional 104,937 shares during the last quarter. Bamco Inc. NY boosted its position in shares of Stevanato Group by 4.5% in the third quarter. Bamco Inc. NY now owns 1,973,759 shares of the company’s stock worth $50,824,000 after acquiring an additional 85,709 shares during the last quarter. Finally, Jennison Associates LLC boosted its position in shares of Stevanato Group by 13.7% in the fourth quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after acquiring an additional 213,602 shares during the last quarter.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.